Assessing Adherence and Persistence to Non-vitamin K Antagonist Oral Anticoagulants (NOACs) among Patients with Atrial Fibrillation in Tertiary-care Referral Centers in Malaysia

INTRODUCTION: Non-vitamin K antagonist oral anticoagulants (NOACs), such as dabigatran and rivaroxaban, are now available for stroke prevention in patients with atrial fibrillation (AF) and are often clinically preferred over vitamin K antagonists (VKAs), such as warfarin. Data describing adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubas, Mohammed A, Shabaruddin, Fatiha Hana, Mazlan-Kepli, Wardati, Jagan, Nirmala, Mohamed, Sahimi, Mohamed Nazar, Nor Ilyani, Zin, Che Suraya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021046/
https://www.ncbi.nlm.nih.gov/pubmed/33828378
http://dx.doi.org/10.4103/jpbs.JPBS_381_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021046/
https://www.ncbi.nlm.nih.gov/pubmed/33828378
http://dx.doi.org/10.4103/jpbs.JPBS_381_19

Ejemplares similares